Evert B. Schimmelpennink

Insider Reports History

Entity
Individual
Location
C/O Pfenex Inc., 10790 Roselle Street, San Diego, California
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Evert B. Schimmelpennink:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LENZ Therapeutics, Inc. President, CEO and Secretary, Director Stock Option (right to buy) 475 K Mar 21, 2024 Direct
iBio, Inc. Director Stock Option (right to buy) 109 K Dec 9, 2021 Direct
Contineum Therapeutics, Inc. Director Stock Option (right to buy) 29.5 K May 24, 2024 Direct

Insider Reports Filed by Evert B. Schimmelpennink

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTNM Contineum Therapeutics, Inc. May 24, 2024 1 $0 4 May 29, 2024 Director
CTNM Contineum Therapeutics, Inc. Apr 4, 2024 0 $0 3 Apr 4, 2024 Director
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 4 $0 4 Mar 25, 2024 President, CEO and Secretary, Director
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 0 $0 3 Mar 25, 2024 President, CEO and Secretary, Director
IBIO iBio, Inc. Dec 9, 2021 1 $0 4 Dec 13, 2021 Director
IBIO iBio, Inc. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director
IBIO iBio, Inc. Jun 7, 2021 0 $0 3 Jun 9, 2021 Director